Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Innospec (0JAX) Share Price & Analysis

0 Followers

0JAX Stock Chart & Stats

$79.84$1.24(1.58%)
At close: 4:30 PM GMT
$80$90$100Aug 14Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$79.00 - $81.11
52-Week Range
$66.00 - $102.85
Previous Close
$78.60
Volume
N/A
Average Volume (3M)
27
Market Cap
$1.95B
Enterprise Value
$2.16B
Total Cash (Recent Filing)
$251.90M
Total Debt (Recent Filing)
$47.30M
Price to Earnings (P/E)
14.2
Beta
0.67
Next Earnings
Feb 11, 2027 (Est.)
EPS Estimate
1.42
Next Dividend Ex-Date
N/A
Dividend Yield
2.23%

Bulls Say, Bears Say

Bulls Say

Debt-free Balance Sheet

The combination of more than $250 million in cash and no debt gives Innospec substantial financial flexibility. This supports organic investment, potential acquisitions, dividends, and buybacks while reducing refinancing pressure and improving resilience if operating conditions weaken.

Broad Earnings Rebound

Companywide revenue and earnings growth across the three operating businesses indicates broad-based recovery rather than reliance on one segment alone. Higher gross margin and EBITDA strengthen internal funding capacity and provide a more durable base for investment and shareholder returns.

Capacity And Product Productivity Upside

The North Carolina investment is aimed at improving capacity, yields, and productivity across existing products while supporting higher-margin commercialization. These operational gains could improve earnings quality and create lasting growth potential as customer demand and product sales recover.

Bears Say

Weaker Cash Conversion

Recent cash generation has lagged accounting earnings, with free cash flow down and representing only about 45% of net income. Higher working-capital needs or capital spending can restrict funds available for investment, dividends, and acquisitions until conversion improves.

Performance Chemicals Volume Pressure

The volume decline shows that price and mix benefits are currently masking weaker underlying demand in Performance Chemicals. A gradual personal-care sales recovery could limit near-term segment expansion and delay the full earnings benefit from planned plant improvements.

Oilfield Services Disruption Risk

Oilfield Services remains exposed to delayed customer activity and elevated input costs, which have already reduced production and stimulation work and pressured margins. Even with expected improvement, continued disruption could slow the segment recovery and keep profitability below potential.

Innospec News

0JAX FAQ

What was Innospec’s price range in the past 12 months?
Innospec lowest share price was $66.00 and its highest was $102.85 in the past 12 months.
What is Innospec’s market cap?
Innospec’s market cap is $1.95B.
When is Innospec’s upcoming earnings report date?
Innospec’s next earnings report is estimated for Feb 11, 2027 (not yet confirmed), which is in 89 days.
How were Innospec’s earnings last quarter?
Innospec released its earnings results on Nov 03, 2026. The company reported $1.29 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.03.
Is Innospec overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Innospec pay dividends?
Innospec does not currently pay dividends.
What is Innospec’s EPS estimate?
Innospec’s EPS estimate is 1.42.
How many shares outstanding does Innospec have?
Innospec has 24,631,596 shares outstanding.
What happened to Innospec’s price movement after its last earnings report?
Innospec reported an EPS of $1.29 in its last earnings report, beating expectations of $1.26. Following the earnings report the stock price went down -16.073%.
Which hedge fund is a major shareholder of Innospec?
Hedge funds hold Innospec shares: the largest hedge-fund position in Innospec is 528,184,422 shares, and hedge funds increased their holdings by 85.5K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology